NITEL CT-40
Description
- Combination of ARB (Telmisartan) and diuretic (Chlorthalidone)
- Dual mechanism for enhanced blood pressure reduction
- Reduces risk of cardiovascular complications (stroke, heart attack)
- Provides 24-hour blood pressure control with once-daily dosing
- Improves kidney and heart protection in hypertensive patients
- Ideal for patients unresponsive to single-drug therapy
- Well-tolerated with a convenient dosing schedule
Composition
TELMISARTAN-40 MG, CHOLTHALIDONE-12.5 MG
Benefits
NITEL CT-40 offers superior blood pressure control through dual-action therapy—vasodilation from Telmisartan and diuresis from Chlorthalidone. It effectively lowers the risk of cardiovascular events such as heart attack, stroke, and heart failure in hypertensive patients. Chlorthalidone’s prolonged action ensures 24-hour efficacy, while Telmisartan provides additional organ protection, particularly for the heart and kidneys. This once-daily tablet improves patient compliance and provides a safe and effective solution for long-term hypertension management.
Introduction
NITEL CT-40 is a fixed-dose combination tablet containing Telmisartan 40 mg and Chlorthalidone 12.5 mg, specially formulated to manage essential hypertension effectively. Telmisartan, an angiotensin II receptor blocker (ARB), helps relax blood vessels by blocking the action of angiotensin II, thereby lowering blood pressure. Chlorthalidone is a long-acting thiazide-like diuretic that reduces excess fluid and sodium in the body, further supporting blood pressure reduction. This combination works synergistically to provide enhanced and sustained antihypertensive effects, making it ideal for patients not adequately controlled on monotherapy.
